Evotec SE
Evotec SE (XETRA: EVT) is trading at €2.81, about ₹307 at today's EUR/INR rate, as of 25 Sep 2026, 11:35 AM ET, up 2.03% today. Indian residents can buy Evotec from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€2.71
Today's high
€2.81
52 week low
€2.71
52 week high
€7.30
EVT opened at €2.78, closed previously at €2.75, and has traded between €2.71 and €7.30 over the past 52 weeks.
About
Evotec SE functions as a global collaborator, aiding the pharmaceutical and biotechnology industries in the identification and progression of novel drug candidates. The firm is actively engaged in advancing medicinal products designed to treat a diverse array of health challenges, including diabetes and its related complications, various fibrotic conditions, infectious diseases, disorders of the central nervous system, oncological conditions, pain management, inflammatory and immunological ailments, rare diseases, respiratory illnesses, and women's health concerns. Evotec SE has forged partnerships with a number of significant players in the sector, such as Bayer AG, Lilly, Chinook Therapeutics, Novo Nordisk A/S, Galapagos, Pfizer Inc., CONBA Pharmaceutical Co., Ltd., Bristol Myers Squibb Company, Zhejiang JingXin Pharmaceutical Co., Ltd, Kazia Therapeutics, Apeiron Biologics, and Takeda Pharmaceuticals. The company, initially incorporated as Evotec AG in 1993, underwent a name change to Evotec SE in April 2019 and maintains its corporate headquarters in Hamburg, Germany.
Key statistics
Avg. volume
823.85K
Market cap
€499.11M
P/E Ratio
-2.54
Price-to-sales ratio
0.70
Enterprise value
€626.62M
Free cash flow yield
-32.46%
Debt-to-equity ratio
0.71
Return on equity
-26.46%
ROIC
-9.58%
Beta
1.26
Dividend yield
0.00%
Last dividend
€0.00
Financial overview
Revenue
€788.37M
Earnings per share
-€0.58
Free cash flow
-€81.98M
Net profit margin
-27.47%
Gross margin
10.49%
EBITDA
-€41.40M
Revenue growth
-1.08%
Similar securities
This is not an investment recommendation
How to buy Evotec from India
Indian residents can buy Evotec shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Evotec and place an order
Find Evotec by name or by its ticker, EVT, and choose an order type. Evotec trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Evotec position in EUR and INR. Evotec pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Evotec from India
Trading and taxes when buying Evotec from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneEvotec does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Evotec stock?
Yes. Evotec (EVT) has been listed on XETRA since 1999, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Evotec share cost in rupees?
One Evotec share is €2.81 — about ₹307 at an EUR/INR rate of 109.24 on 24 Sep 2026. Both the Evotec price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Evotec from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Evotec shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Evotec price. Paasa issues a capital-gains statement for your return.
Does Evotec pay a dividend?
No. Evotec does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Evotec from India?
XETRA trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Germany is on standard time. Orders can only execute during that window.
Do I have to declare Evotec shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Evotec holding, its cost and its closing value.
How do I sell Evotec and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Evotec?
Yes. Evotec is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.